Claudia Leucht

2.8k total citations · 1 hit paper
20 papers, 1.6k citations indexed

About

Claudia Leucht is a scholar working on Psychiatry and Mental health, Pharmacology and Philosophy. According to data from OpenAlex, Claudia Leucht has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 5 papers in Philosophy. Recurrent topics in Claudia Leucht's work include Schizophrenia research and treatment (16 papers), Treatment of Major Depression (8 papers) and Mental Health and Psychiatry (5 papers). Claudia Leucht is often cited by papers focused on Schizophrenia research and treatment (16 papers), Treatment of Major Depression (8 papers) and Mental Health and Psychiatry (5 papers). Claudia Leucht collaborates with scholars based in Germany, United States and United Kingdom. Claudia Leucht's co-authors include Stefan Leucht, John M. Davis, John M. Kane, Maximilian Huhn, Werner Kissling, Myrto Samara, Stephan Heres, Bartosz Helfer, Taishiro Kishimoto and Michael Borenstein and has published in prestigious journals such as American Journal of Psychiatry, Brain and Cochrane Database of Systematic Reviews.

In The Last Decade

Claudia Leucht

17 papers receiving 1.5k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors

2017 350 citations Stefan Leucht, Claudia Leucht et al. American Journal of Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Leucht Germany	14	1.2k	410	333	286	162	20	1.6k
Magdolna Tardy Germany	10	1.0k 0.8×	384 0.9×	277 0.8×	205 0.7×	132 0.8×	13	1.4k
Caroline Corves Germany	6	1.7k 1.4×	360 0.9×	369 1.1×	311 1.1×	138 0.9×	11	2.2k
J. Peuskens Belgium	11	1.2k 1.0×	436 1.1×	272 0.8×	274 1.0×	159 1.0×	19	1.9k
S. Leucht Germany	11	1.7k 1.4×	555 1.4×	593 1.8×	308 1.1×	193 1.2×	19	2.2k
Spyridon Siafis Germany	22	985 0.8×	258 0.6×	184 0.6×	250 0.9×	102 0.6×	79	1.6k
Ibrahim Turkoz United States	22	1.3k 1.1×	411 1.0×	199 0.6×	566 2.0×	184 1.1×	98	1.8k
Luchezar Hranov Israel	9	1.1k 0.9×	319 0.8×	275 0.8×	179 0.6×	132 0.8×	17	1.3k
Michael J. Sernyak United States	26	1.3k 1.1×	305 0.7×	229 0.7×	219 0.8×	91 0.6×	58	1.9k
Philipp Rothe Germany	10	1.1k 0.9×	234 0.6×	193 0.6×	242 0.8×	119 0.7×	17	1.4k
Douglas L. Boggs United States	18	989 0.8×	275 0.7×	208 0.6×	711 2.5×	112 0.7×	30	1.8k

Countries citing papers authored by Claudia Leucht

Since Specialization

Citations

This map shows the geographic impact of Claudia Leucht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Leucht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Leucht more than expected).

Fields of papers citing papers by Claudia Leucht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Leucht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Leucht. The network helps show where Claudia Leucht may publish in the future.

Co-authorship network of co-authors of Claudia Leucht

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Leucht. A scholar is included among the top collaborators of Claudia Leucht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Leucht. Claudia Leucht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leucht, Stefan, Bettina König, Alessandro Rodolico, et al.. (2025). Enhancing mental health care: a problem, resources and goals oriented multidimensional framework (PRoGO). European Archives of Psychiatry and Clinical Neuroscience. 276(1). 51–61.

Samara, Myrto, Bartosz Helfer, Claudia Leucht, et al.. (2025). Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia. Cochrane Database of Systematic Reviews. 2025(4). CD011885–CD011885.

Brandl, Felix, Franziska Knolle, Mihai Avram, et al.. (2022). Negative symptoms, striatal dopamine and model-free reward decision-making in schizophrenia. Brain. 146(2). 767–777. 13 indexed citations

Avram, Mihai, Michel J. Grothe, Claudia Leucht, et al.. (2021). Lower cholinergic basal forebrain volumes link with cognitive difficulties in schizophrenia. Neuropsychopharmacology. 46(13). 2320–2329. 20 indexed citations

Huhn, Maximilian, Claudia Leucht, Philipp Rothe, et al.. (2020). Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial. European Archives of Psychiatry and Clinical Neuroscience. 271(2). 293–302. 27 indexed citations

Avram, Mihai, Felix Brandl, Franziska Knolle, et al.. (2020). Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia. Brain. 143(11). 3495–3505. 22 indexed citations

Cabello, Jorge, Mihai Avram, Felix Brandl, et al.. (2019). Impact of non-uniform attenuation correction in a dynamic [18F]-FDOPA brain PET/MRI study. EJNMMI Research. 9(1). 77–77. 4 indexed citations

Bighelli, Irene, et al.. (2019). Are Randomized Controlled Trials on Pharmacotherapy and Psychotherapy for Positive Symptoms of Schizophrenia Comparable? A Systematic Review of Patient and Study Characteristics. Schizophrenia Bulletin. 46(3). 496–504. 11 indexed citations

Leucht, Stefan, Anna Chaimani, Dimitris Mavridis, et al.. (2019). Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis. Neuropsychopharmacology. 44(11). 1955–1966. 25 indexed citations

10.

Avram, Mihai, Felix Brandl, Jorge Cabello, et al.. (2019). Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms. Brain. 142(6). 1813–1826. 41 indexed citations

11.

Leucht, Stefan, Anna Chaimani, Claudia Leucht, et al.. (2018). 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response. Schizophrenia Research. 201. 315–323. 27 indexed citations

12.

Leucht, Stefan, Claudia Leucht, Maximilian Huhn, et al.. (2017). Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. American Journal of Psychiatry. 174(10). 927–942. 350 indexed citations breakdown →

13.

Helfer, Bartosz, Myrto Samara, Maximilian Huhn, et al.. (2016). Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis. American Journal of Psychiatry. 173(9). 876–886. 145 indexed citations

14.

Huhn, Maximilian, Magdolna Tardy, Loukia M. Spineli, et al.. (2014). Efficacy of Pharmacotherapy and Psychotherapy for Adult Psychiatric Disorders. JAMA Psychiatry. 71(6). 706–706. 199 indexed citations

15.

Leucht, Claudia, Maximilian Huhn, & Stefan Leucht. (2012). Amitriptyline versus placebo for major depressive disorder. Cochrane Database of Systematic Reviews. 2012(12). CD009138–CD009138. 35 indexed citations

16.

Kishimoto, Taishiro, Claudia Leucht, S. Leucht, et al.. (2012). Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials. Schizophrenia Bulletin. 40(1). 192–213. 296 indexed citations

17.

Leucht, Claudia, Stephan Heres, John M. Kane, et al.. (2011). Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials. Schizophrenia Research. 127(1-3). 83–92. 319 indexed citations

18.

Leucht, Claudia, et al.. (2011). Synergie oder Profilverlust? Potentiale und Probleme einer gemeinsamen Regionalvermarktung ökologischer und konventioneller Produkte. Organic Eprints (International Centre for Research in Organic Food Systems, and Research Institute of Organic Agriculture).

19.

Leucht, Claudia, et al.. (2008). Haloperidol versus chlorpromazine for schizophrenia. Cochrane Database of Systematic Reviews. 2013(2). CD004278–CD004278. 36 indexed citations

20.

Leucht, Claudia, et al.. (2008). Haloperidol versus chlorpromazine for treatment of schizophrenia. Schizophrenia Bulletin. 34(5). 813–815. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact